• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Clinical and pathological studies of renal cell carcinoma with vein involvement].

作者信息

Kitamura Y, Watanabe M, Komatsubara S, Sakata Y

机构信息

Department of Urology, Niigata Cancer Center Hospital.

出版信息

Hinyokika Kiyo. 1995 Oct;41(10):755-9.

PMID:8533669
Abstract

To clarify the meaning of vein involvement, the clinical and pathological findings of the patients with renal cell carcinoma were examined. Out of 288 patients treated for renal cell carcinoma-from 1961 to 1993 at Niigata Cancer Center Hospital, 238 patients were examined for vein involvement. Tumor stages were evaluated according to the general rules for clinical and pathological studies on renal cell carcinoma (2nd edition). In 154 patients, the stage was pV0, in 41 pV1a, in 23 pV1b and in 20 pV2. The 5-year survival rate was 72.2% in pV0, 60.1% in pV1a, 51.9% in pV1b and 30.0% in pV2. Histological findings as grade, tumor size, regional lymph node metastasis and distant metastasis were proportional to vein involvement. The difference in the survival rate and histological findings of primary tumor between pV1a and pV1b group was small but the difference between pV0 and pV1a was significant. Therefore, the histological and clinical studies of the cases with pV1a must be done carefully. The 5-year survival rate of the patients with pV2 and without distant metastasis was 50.0%. However, the prognosis of the patients with pV2 and with distant metastasis was poor. Therefore aggressive treatment was not recommended for these patients.

摘要

相似文献

1
[Clinical and pathological studies of renal cell carcinoma with vein involvement].
Hinyokika Kiyo. 1995 Oct;41(10):755-9.
2
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.肾静脉及下腔静脉受累在肾细胞癌中的预后价值
Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.
3
Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.累及肾静脉和下腔静脉的肾细胞癌:临床病理特征、手术技术及预后
J Urol. 2005 Jun;173(6):1897-902. doi: 10.1097/01.ju.0000158459.42658.95.
4
Tumor thrombus and microvascular invasion as prognostic factors in renal cell carcinoma.肿瘤血栓和微血管侵犯作为肾细胞癌的预后因素
Jpn J Clin Oncol. 1991 Oct;21(5):340-5.
5
[Venous tumor invasion by renal cell carcinoma. Surgical technique, complications and survival rate].[肾细胞癌的静脉肿瘤侵犯。手术技术、并发症及生存率]
Urologe A. 1994 Sep;33(5):440-6.
6
[Outcome of surgical management of renal cell carcinoma with renal vein or inferior vena cava tumor thrombus].[肾静脉或下腔静脉瘤栓的肾细胞癌手术治疗结果]
Zhonghua Wai Ke Za Zhi. 2006 May 15;44(10):678-80.
7
Editorial comment on: Prognosis value of renal vein and inferior vena cava involvement in renal cell carcinoma.关于“肾静脉及下腔静脉受累在肾细胞癌中的预后价值”的编辑评论
Eur Urol. 2009 Feb;55(2):459. doi: 10.1016/j.eururo.2008.07.054. Epub 2008 Aug 5.
8
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.伴有下腔静脉侵犯的转移性肾细胞癌:根治性肾切除术、腔静脉血栓切除术及术后免疫治疗联合治疗后的长期生存情况
J Urol. 1999 Jul;162(1):46-50. doi: 10.1097/00005392-199907000-00012.
9
Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.伴有肿瘤血栓延伸至腔静脉的肾细胞癌:前瞻性长期随访
J Urol. 2007 May;177(5):1703-8. doi: 10.1016/j.juro.2007.01.039.
10
A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.局部进展期(pT3 - 4)肾细胞癌的一种新分期系统:一项纳入2000例患者的欧洲多中心研究。
J Urol. 2007 Aug;178(2):418-24; discussion 423-4. doi: 10.1016/j.juro.2007.03.104. Epub 2007 Jun 11.